U.S. flag

An official website of the United States government

NM_000512.5(GALNS):c.812T>C (p.Leu271Pro) AND Mucopolysaccharidosis, MPS-IV-A

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 1, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001578521.3

Allele description [Variation Report for NM_000512.5(GALNS):c.812T>C (p.Leu271Pro)]

NM_000512.5(GALNS):c.812T>C (p.Leu271Pro)

Gene:
GALNS:galactosamine (N-acetyl)-6-sulfatase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
16q24.3
Genomic location:
Preferred name:
NM_000512.5(GALNS):c.812T>C (p.Leu271Pro)
HGVS:
  • NC_000016.10:g.88835299A>G
  • NG_008667.1:g.26668T>C
  • NM_000512.5:c.812T>CMANE SELECT
  • NM_001323543.2:c.257T>C
  • NM_001323544.2:c.830T>C
  • NP_000503.1:p.Leu271Pro
  • NP_001310472.1:p.Leu86Pro
  • NP_001310473.1:p.Leu277Pro
  • NC_000016.9:g.88901707A>G
Protein change:
L271P
Links:
dbSNP: rs1912001607
NCBI 1000 Genomes Browser:
rs1912001607
Molecular consequence:
  • NM_000512.5:c.812T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001323543.2:c.257T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001323544.2:c.830T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Mucopolysaccharidosis, MPS-IV-A (MPS4A)
Synonyms:
MPS IVA; Morquio syndrome A; MPS 4A; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009659; MedGen: C0086651; Orphanet: 309297; Orphanet: 582; OMIM: 253000

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001547802Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Feb 1, 2021)
germlinecuration

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedcuration

Citations

PubMed

Clinical, biochemical and genetic profiles of patients with mucopolysaccharidosis type IVA (Morquio A syndrome) in Malaysia: the first national natural history cohort study.

Leong HY, Abdul Azize NA, Chew HB, Keng WT, Thong MK, Mohd Khalid MKN, Hung LC, Mohamed Zainudin N, Ramlee A, Md Haniffa MA, Yakob Y, Ngu LH.

Orphanet J Rare Dis. 2019 Jun 14;14(1):143. doi: 10.1186/s13023-019-1105-6.

PubMed [citation]
PMID:
31200731
PMCID:
PMC6570902

Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome): A review and classification of GALNS gene variants and reporting of 68 novel variants.

Zanetti A, D'Avanzo F, AlSayed M, Brusius-Facchin AC, Chien YH, Giugliani R, Izzo E, Kasper DC, Lin HY, Lin SP, Pollard L, Singh A, Tonin R, Wood T, Morrone A, Tomanin R.

Hum Mutat. 2021 Nov;42(11):1384-1398. doi: 10.1002/humu.24270. Epub 2021 Aug 23. Review.

PubMed [citation]
PMID:
34387910
PMCID:
PMC9291100
See all PubMed Citations (3)

Details of each submission

From Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova, SCV001547802.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (3)

Description

Absent from gnomAD v2.1.1 (PM2_moderate)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 24, 2023